Logo image of LLY.DE

ELI LILLY & CO (LLY.DE) Stock Overview

FRA:LLY - US5324571083 - Common Stock

622 EUR
-13.6 (-2.14%)
Last: 9/5/2025, 7:00:00 PM

LLY.DE Key Statistics, Chart & Performance

Key Statistics
52 Week High888.3
52 Week Low535.8
Market Cap588.70B
Shares946.46M
Float944.35M
Yearly Dividend4.22
Dividend Yield0.81%
EPS(TTM)13.87
PE44.84
Fwd PE23.73
Earnings (Next)10-30 2025-10-30/bmo
IPO07-09 1970-07-09
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


LLY.DE short term performance overview.The bars show the price performance of LLY.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20

LLY.DE long term performance overview.The bars show the price performance of LLY.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 40 60 80

The current stock price of LLY.DE is 622 EUR. In the past month the price increased by 14.76%. In the past year, price decreased by -23.48%.

ELI LILLY & CO / LLY Daily stock chart

LLY.DE Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
1LLY.MI ELI LILLY & CO 44.78 587.85B
ZEG.DE ASTRAZENECA PLC 18.4 432.52B
JNJ.DE JOHNSON & JOHNSON 17.77 367.61B
RHO.DE ROCHE HOLDING AG-BR 14.74 250.06B
NOT.DE NOVARTIS AG-REG 14.78 214.61B
NOV.DE NOVO NORDISK A/S-B 14.08 209.02B
SAN.PA SANOFI 10.53 193.90B
SNW.DE SANOFI 10.53 193.90B
1SAN.MI SANOFI 10.52 193.75B
1MRKX.MI MERCK & CO. INC. 11.06 182.59B
6MK.DE MERCK & CO. INC. 10.91 180.09B
PFE.DE PFIZER INC 7.23 119.57B

About LLY.DE

Company Profile

LLY logo image Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs 47,000 full-time employees. Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, and VERVE-301. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The Company, through its subsidiary, POINT Biopharma Global Inc., is engaged in radiopharmaceutical discovery, development, and manufacturing efforts, as well as clinical and pre-clinical radioligand therapies in development for the treatment of cancer. The company is also developing an oral small molecule inhibitor of a4b7 integrin for inflammatory bowel disease (IBD).

Company Info

ELI LILLY & CO

Lilly Corporate Ctr, Drop Code 1094

Indianapolis INDIANA US

Employees: 47000

LLY Company Website

LLY Investor Relations

Phone: 13172762000

ELI LILLY & CO / LLY.DE FAQ

What is the stock price of ELI LILLY & CO today?

The current stock price of LLY.DE is 622 EUR. The price decreased by -2.14% in the last trading session.


What is the ticker symbol for ELI LILLY & CO stock?

The exchange symbol of ELI LILLY & CO is LLY and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is LLY.DE stock listed?

LLY.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for ELI LILLY & CO stock?

35 analysts have analysed LLY.DE and the average price target is 766.66 EUR. This implies a price increase of 23.26% is expected in the next year compared to the current price of 622. Check the ELI LILLY & CO stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ELI LILLY & CO worth?

ELI LILLY & CO (LLY.DE) has a market capitalization of 588.70B EUR. This makes LLY.DE a Mega Cap stock.


How many employees does ELI LILLY & CO have?

ELI LILLY & CO (LLY.DE) currently has 47000 employees.


What are the support and resistance levels for ELI LILLY & CO (LLY.DE) stock?

ELI LILLY & CO (LLY.DE) has a support level at 543.18 and a resistance level at 636.84. Check the full technical report for a detailed analysis of LLY.DE support and resistance levels.


Is ELI LILLY & CO (LLY.DE) expected to grow?

The Revenue of ELI LILLY & CO (LLY.DE) is expected to grow by 36.89% in the next year. Check the estimates tab for more information on the LLY.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ELI LILLY & CO (LLY.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ELI LILLY & CO (LLY.DE) stock pay dividends?

ELI LILLY & CO (LLY.DE) has a dividend yield of 0.81%. The yearly dividend amount is currently 4.22. Check the full fundamental report for a detailed analysis of LLY.DE dividend history, reliability and sustainability.


When does ELI LILLY & CO (LLY.DE) report earnings?

ELI LILLY & CO (LLY.DE) will report earnings on 2025-10-30, before the market open.


What is the Price/Earnings (PE) ratio of ELI LILLY & CO (LLY.DE)?

The PE ratio for ELI LILLY & CO (LLY.DE) is 44.84. This is based on the reported non-GAAP earnings per share of 13.87 and the current share price of 622 EUR. Check the full fundamental report for a full analysis of the valuation metrics for LLY.DE.


LLY.DE Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to LLY.DE. When comparing the yearly performance of all stocks, LLY.DE is a bad performer in the overall market: 92.11% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

LLY.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to LLY.DE. While LLY.DE has a great profitability rating, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LLY.DE Financial Highlights

Over the last trailing twelve months LLY.DE reported a non-GAAP Earnings per Share(EPS) of 13.87. The EPS increased by 77.67% compared to the year before.


Industry RankSector Rank
PM (TTM) 25.91%
ROA 13.67%
ROE 75.52%
Debt/Equity 1.87
Chartmill High Growth Momentum
EPS Q2Q%60.97%
Sales Q2Q%37.64%
EPS 1Y (TTM)77.67%
Revenue 1Y (TTM)36.83%

LLY.DE Forecast & Estimates

35 analysts have analysed LLY.DE and the average price target is 766.66 EUR. This implies a price increase of 23.26% is expected in the next year compared to the current price of 622.

For the next year, analysts expect an EPS growth of 76.85% and a revenue growth 36.89% for LLY.DE


Analysts
Analysts80
Price Target766.66 (23.26%)
EPS Next Y76.85%
Revenue Next Year36.89%

LLY.DE Ownership

Ownership
Inst Owners84.01%
Ins Owners0.16%
Short Float %N/A
Short RatioN/A